subscribe
 

Drug Discovery/Development

Improving drug delivery

Developing microfluidic routes to effective nanoparticle drug delivery systems

Enhancing drug discovery

Developing microfluidic routes to effective nanoparticle drug delivery systems

Cloud-based data analytics platform

Data analysis and clinical trial software specialist, Exploristics, has announced plans to launch an updated version of its cloud-based data analytics platform for clinical trial design, KerusCloud 2.0, by the end of the summer.

Subscribe


New instrument for antimicrobial susceptibility testing

Instrument uses gold standard broth microdilution method to guide more targeted patient therapy and optimise patient outcomes

What are the trends in HCS?

High-content screening of complex physiologically relevant cell models

Updated clinical trial design tool

Data analysis and clinical trial software specialist, Exploristics, has announced plans to launch an updated version of its cloud-based data...

Mouse bispecific antibody reagents launched

Absolute Antibody launches mouse bispecific antibody reagents: novel fully murine knob-into-hole antibodies for immunotherapy research and...

Drug discovery collaboration

Sygnature Discovery, a leading independent integrated drug discovery and pre-clinical services company, has announced a collaboration with...

Mini-centrifuge opens new organ-on-chip possibilities

A simple innovation the size of a grain of sand means we can now analyse cells and tiny particles as if they were inside the human body

Automated endotoxin detection

Lonza’s fully automated plate-based robotic solution enables simple, fast and reliable endotoxin detection

HD reactors aid workflow

Walk-away process development with Syrris' Atlas reactors: case study shows HD reactors accelerate product development

New XF-platform drug formulations

Biotech firm Destiny Pharma appoints MedPharm as expert partner to develop new XF-platform drug formulations

Platform for ultrahigh-content imaging

Early access program to fully automated, cyclic, high-content immunofluorescence-based imaging

New spheroid-forming human hepatocytes

Lonza’s newly launched spheroid-forming human hepatocytes facilitate improved in vitro liver model systems

New project to improve ovarian cancer treatment

Porvair Sciences reports on its involvement in a new £2.6 million project led by Swansea University (UK) that aims to dramatically improve...

Breakthrough opens path to new vaccine for HIV

A CEA-Leti breakthrough has opened the path to a new vaccine for using lipid-nanoparticle-delivery technology

New pooled donor suspension hepatocytes

Lonza’s new pooled donor suspension hepatocytes enable the next level of reliability, robustness and customisability

Characterising liposomes

Testa Analytical Solutions reports on customers using its Nanobrook ZetaPALS instrument for characterising liposomes and liposome-drug...

Drug discovery institute identifies Huntington's leads

Alborada Drug Discovery Institute identifies advanced Huntington's leads using BioAscent's Compound Cloud library

New biological entity characterisation

Sartorius Stedim Biotech has announced that it will now be offering services for characterisation of new biological entities (NBE)

Pages

Newsbrief

Twitter Icon © Setform Limited
subscribe